GOG Foundation, Inc. Report issue

Foundation Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2017
NCT03398655
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

GOG Foundation | GOG Foundation, Inc. | GOG Foundation, Inc. (GOG Foundation) | The GOG Foundation, Inc.